Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
1.210
+0.010 (0.83%)
Mar 14, 2025, 4:00 PM EST - Market closed
LIXT Employees
As of December 31, 2023, Lixte Biotechnology Holdings had 4 total employees, including 3 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,000,132
Market Cap
2.72M
Employees Chart
LIXT News
- 18 days ago - LIXTE Adds Northwestern University's Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer - GlobeNewsWire
- 4 weeks ago - LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 4 weeks ago - LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 4 weeks ago - LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement - GlobeNewsWire
- 6 months ago - LIXTE Receives U.S. Patent Issue Notification for Immune Oncology - GlobeNewsWire
- 7 months ago - First Patient Dosed with LIXTE's LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - GlobeNewsWire
- 7 months ago - LIXTE Biotechnology Provides Update On Recent Activities and Developments - GlobeNewsWire
- 7 months ago - LIXTE Biotechnology Holdings to Present at Two Investor Conferences - GlobeNewsWire